Phase 2 Evaluation of Parainfluenza Type 3 Cold Passage Mutant 45 Live Attenuated Vaccine in Healthy Children 6-18 Months Old
Version 2 2024-06-13, 15:30Version 2 2024-06-13, 15:30
Version 1 2022-03-31, 12:24Version 1 2022-03-31, 12:24
journal contribution
posted on 2024-06-13, 15:30authored byRB Belshe, FK Newman, TF Tsai, RA Karron, K Reisinger, D Roberton, H Marshall, R Schwartz, J King, FW Henderson, W Rodriguez, JM Severs, PF Wright, H Keyserling, GA Weinberg, K Bromberg, R Loh, P Sly, P McIntyre, JB Ziegler, J Hackell, A Deatly, A Georgiu, M Paschalis, SL Wu, JM Tatem, B Murphy, E Anderson
Phase 2 Evaluation of Parainfluenza Type 3 Cold Passage Mutant 45 Live Attenuated Vaccine in Healthy Children 6-18 Months Old